234 related articles for article (PubMed ID: 11386492)
1. Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone.
Waldinger MD; Zwinderman AH; Olivier B
J Clin Psychopharmacol; 2001 Jun; 21(3):293-7. PubMed ID: 11386492
[TBL] [Abstract][Full Text] [Related]
2. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
Waldinger MD; Hengeveld MW; Zwinderman AH; Olivier B
J Clin Psychopharmacol; 1998 Aug; 18(4):274-81. PubMed ID: 9690692
[TBL] [Abstract][Full Text] [Related]
3. SSRIs and ejaculation: a double-blind, randomized, fixed-dose study with paroxetine and citalopram.
Waldinger MD; Zwinderman AH; Olivier B
J Clin Psychopharmacol; 2001 Dec; 21(6):556-60. PubMed ID: 11763001
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants and ejaculation: a double-blind, randomized, fixed-dose study with mirtazapine and paroxetine.
Waldinger MD; Zwinderman AH; Olivier B
J Clin Psychopharmacol; 2003 Oct; 23(5):467-70. PubMed ID: 14520123
[TBL] [Abstract][Full Text] [Related]
5. On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment.
Waldinger MD; Zwinderman AH; Olivier B
Eur Urol; 2004 Oct; 46(4):510-5; discussion 516. PubMed ID: 15363569
[TBL] [Abstract][Full Text] [Related]
6. Relevance of seminal plasma nitric oxide levels and the efficacy of SSRI treatment on lifelong premature ejaculation.
Kirecci SL; Simsek A; Yuksel A; Gurdal H; Gurbuz ZG; Usanmaz S
Andrologia; 2014 Dec; 46(10):1169-75. PubMed ID: 24354496
[TBL] [Abstract][Full Text] [Related]
7. Relevance of serum nitric oxide levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation: decreased nitric oxide is associated with premature ejaculation.
Otunctemur A; Ozbek E; Kirecci SL; Ozcan L; Dursun M; Cekmen M; Ozdogan HK
Andrologia; 2014; 46(9):951-5. PubMed ID: 24118023
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.
Safarinejad MR
Clin Neuropharmacol; 2006; 29(5):243-52. PubMed ID: 16960468
[TBL] [Abstract][Full Text] [Related]
9. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial.
Sharpley AL; Williamson DJ; Attenburrow ME; Pearson G; Sargent P; Cowen PJ
Psychopharmacology (Berl); 1996 Jul; 126(1):50-4. PubMed ID: 8853216
[TBL] [Abstract][Full Text] [Related]
10. The Oxytocin Antagonist Cligosiban Prolongs Intravaginal Ejaculatory Latency and Improves Patient-Reported Outcomes in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Trial (PEPIX).
McMahon C; Althof S; Rosen R; Giuliano F; Miner M; Osterloh IH; Muirhead GJ; Harty B;
J Sex Med; 2019 Aug; 16(8):1178-1187. PubMed ID: 31351659
[TBL] [Abstract][Full Text] [Related]
11. Once-daily high-dose pindolol for paroxetine-refractory premature ejaculation: a double-blind, placebo-controlled and randomized study.
Safarinejad MR
J Clin Psychopharmacol; 2008 Feb; 28(1):39-44. PubMed ID: 18204339
[TBL] [Abstract][Full Text] [Related]
12. The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Phase IIb trial (PEDRIX).
Althof S; Osterloh IH; Muirhead GJ; George K; Girard N;
J Sex Med; 2019 Aug; 16(8):1188-1198. PubMed ID: 31351660
[TBL] [Abstract][Full Text] [Related]
13. Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy.
Waldinger MD; Zwinderman AH; Olivier B; Schweitzer DH
J Sex Med; 2008 Feb; 5(2):492-9. PubMed ID: 18179458
[TBL] [Abstract][Full Text] [Related]
14. Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study.
Waldinger MD; Hengeveld MW; Zwinderman AH
Br J Urol; 1997 Apr; 79(4):592-5. PubMed ID: 9126089
[TBL] [Abstract][Full Text] [Related]
15. Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity.
Sargent P; Williamson DJ; Pearson G; Odontiadis J; Cowen PJ
Psychopharmacology (Berl); 1997 Aug; 132(3):296-302. PubMed ID: 9292630
[TBL] [Abstract][Full Text] [Related]
16. Association Between Changes in Serum 5-Hydroxy-Tryptamine Concentrations and Improvement in Clinical Symptoms in Primary Premature Ejaculation with Paroxetine Treatment.
Guo Y; Wang Y; Wang X; Ye G; Jiang Y; Xiong W
Med Sci Monit; 2015 Aug; 21():2521-7. PubMed ID: 26305631
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study.
Kim SC; Seo KK
J Urol; 1998 Feb; 159(2):425-7. PubMed ID: 9649255
[TBL] [Abstract][Full Text] [Related]
18. Acupuncture versus paroxetine for the treatment of premature ejaculation: a randomized, placebo-controlled clinical trial.
Sunay D; Sunay M; Aydoğmuş Y; Bağbancı S; Arslan H; Karabulut A; Emir L
Eur Urol; 2011 May; 59(5):765-71. PubMed ID: 21256670
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Preskorn SH
J Clin Psychiatry; 1995; 56 Suppl 6():12-21. PubMed ID: 7649968
[TBL] [Abstract][Full Text] [Related]
20. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
Ferguson JM; Shrivastava RK; Stahl SM; Hartford JT; Borian F; Ieni J; McQuade RD; Jody D
J Clin Psychiatry; 2001 Jan; 62(1):24-9. PubMed ID: 11235924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
